Shares of 180 Life Sciences Corp (NASDAQ: ATNF), soon to be rebranded as ETHZilla, surged 5.47% in Tuesday's trading session, building on recent momentum following significant developments in the company's strategic direction.

The biotechnology company's stock price jump comes on the heels of several key announcements that have dramatically shifted investor perception: 1. Billionaire Peter Thiel and his investment team have acquired a 7.5% stake in the company, according to a recent SEC filing. 2. The company has revealed plans to rebrand as ETHZilla, positioning itself as an Ethereum treasury reserve company. 3. ATNF announced holdings of 82,186 Ethereum tokens, valued at approximately $349 million. 4. The company completed a $156 million private offering to further boost its Ethereum reserves.

This strategic pivot towards becoming an Ethereum-focused investment vehicle has clearly resonated with investors. The involvement of high-profile tech investor Peter Thiel lends significant credibility to the company's new direction, while the substantial Ethereum holdings provide a tangible asset base that aligns with growing interest in cryptocurrency investments.

As the crypto market continues to evolve and institutional interest in digital assets grows, ATNF's transformation into ETHZilla positions it uniquely in the public markets. Investors appear to be betting on the potential for this Ethereum treasury model to capture value from the cryptocurrency's future growth and adoption.

While the stock has seen significant volatility in recent trading sessions, today's 5.47% gain suggests ongoing investor optimism about the company's new strategy. As always, potential investors should conduct their own research and consider the risks associated with both cryptocurrency investments and newly pivoting companies.